Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT06043700

A Community-Based Screening Program to Identify Participants at High Risk for Amyloid Pathology

Sponsor: Eisai Limited

View on ClinicalTrials.gov

Summary

The primary purpose of this study is to identify participants with or without symptoms of Alzheimer's Disease (AD) that are at high risk for brain amyloid pathology using blood-based biomarkers.

Official title: A Community-Based Screening Program to Identify, Using Blood-Based Biomarkers, Individuals With or Without Alzheimer's Disease Symptoms Who Are at High Risk for Brain Amyloid Pathology

Key Details

Gender

All

Age Range

50 Years - 80 Years

Study Type

OBSERVATIONAL

Enrollment

2000

Start Date

2023-09-12

Completion Date

2028-03-31

Last Updated

2026-03-05

Healthy Volunteers

Yes

Interventions

OTHER

No Intervention

No treatment intervention will be administered.

Locations (3)

Eisai Site #3

Clermont, Florida, United States

Eisai Site #1

Lady Lake, Florida, United States

Eisai Site #2

District Heights, Maryland, United States